Innovating Works

COLOROBBIA ESPAÑA SOCIEDAD ANONIMA

Activa
SN-marker: Secretoneurin SN the first blood biomarker to accurately stratify mortality risk in patients with... Innovasjon Norge tramitó un H2020: H2020-EIC-SMEInst-2018-2020 Cardiovascular disease (CVD) is the no. 1 killer worldwide. At least half of CVD deaths is caused by ventricular arrhythmias that lead to su...
2019-09-19 - 2020-02-29 | Financiado
UNIFLUVAC: A novel universal influenza vaccine targeting epitopes of limited variability THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD tramitó un H2020: ERC-2018-PoC The antigenic evolution of influenza is conventionally assumed to occur by ‘antigenic drift’ where new strains arise through the incremental...
2018-08-10 - 2020-03-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.